prvi bosansko-hercegovački i drugi jadranski kongres ...

More documents

Recommendations

Info

2 COMPARISON OF DRUGS CONSUMPTION IN TWO CROATIAN COUNTY GENERAL HOSPITALS Aleksandar Knežević, Mila Basioli, Hana Kalinić Grgorinić . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24 BURDEN OF COMMUNITY ACQUIRED PNEUMONIA IN CENTRAL EUROPEAN COUNTRIES Ales Tichopad, C . Roberts, A . Skoczynska, I . Gembula, K . Jahnz-Rozyk . . . . . . . . . . . . . . . . . . . . . . . . . . . . 25 THE ROLE OF HEALTH AUTHORITIES IN PROMOTION OF RATIONAL USE OF ANTIBIOTICS Merjem Hadjihamza . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 PHARMACOECONOMIC ANALYSIS COMPARING THE USE OF CIPROFLOXACIN AND METRONIDAZOLE VERSUS ERTAPENEM IN PROPHYLAXIS OF MAYOR SURGICAL PROCEDURES AT THE UNIVERSITY HOSPITAL REBRO Ivana Čegec, Robert Likic, Ksenija Makar Ausperger, Viktorija Erdeljic, Matea Radacic Aumiler, Danica Juricic Nahal, Luka Bielen, Iva Kraljickovic, Igor Francetic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 IMPACT OF CEFTRIAXONE DE-RESTRICTION ON THE COST OF ANTIBIOTIC TREATMENT Srecko Marusic, Vesna Bacic-Vrca, Jasenka Skrlin, Lado Uglesic . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 IMPACT OF THE PHARMA ECONOMIC ACT ON DIFFUSION OF INNOVATION, REDUCTION OF COSTS AND PATIENTS’ EQUITY IN THE HUNGARIAN PRESCRIPTION DRUG MARKET Rok Hren . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 29 ETHICS AS A RISING ISSUE FOR TARGETED THERAPIES: THE METASTATIC COLORECTAL EXAMPLE Livio Garattini, Katelijne van de Vooren . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 IMPLEMENTATION OF BIOLOGICAL THERAPY AND SURGERY IN THE TREATMENT OF METASTATIC COLORECTAL CANCER: ARE THE COSTS JUSTIFIED? Renata Dobrila-Dintinjana, Dinko Vitezić . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31 THE ROLE OF CYTOLOGY IN DETECTION OF SMALL BREAST CANCER – EXPERIENCE OF UNIVERSITY HOSPITAL FOR TUMOURS, ZAGREB (COST BENEFIT?) Vesna Ramljak, Iva Bobuš-Kelčec, Merdita Agai, Ljiljana Mayer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32 COMPARATIVE ANALYSIS OF PATIENT ACCESS TO TARGETED THERAPIES FOR METASTATIC RENAL CELL CARCINOMA (MRCC) IN SELECTED CEE COUNTRIES Jasmina Krehić, Novka Agić, Vedrana Raguž . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 PHARMACOECONOMICS IN PREDICTIVE MEDICINE Josip Čulig, Marcel Leppee, Nikolina Skaron-Jakobović . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 34 THE ECONOMIC COST ANALYSIS OF THE IMPLEMENTATION OF CENTRALIZED PHARMACY UNIT FOR ANTINEOPLASTIC DRUGS WITH RESPECT TO THE PREMISES, EQUIPMENT AND TECHNICAL STAFF UNDER THE SUPERVISION OF ONCOLOGY PHARMACIST Vesna Pavlica, Damir Vrbanec, Velemir Danko Vrdoljak . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 MUSCULOSKELETAL DISORDER - THEIR IMPACT ON WORK ABILITY AND SOCIETAL COSTS IN POLAND Magdalena Wladysiuk, Ksenia Zhelthoukhova, Stephen Bevan, Mateusz Haldas . . . . . . . . . . . . . . . . . 36
CASE STUDY IN TRANSPLANTATION AND IMMUNOSUPPRESSANT THERAPY IN MACEDONIA, THREE YEAR FOLLOW UP Stevce Acevski, Zoran Sterjev, Vladimir Indov . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 37 RARE DISEASES OR DISORDERS, ORPHAN DRUGS AND PATIENTS EQUITY RIGHTS Jasmina Krehić, Senka Mesihović Dinarević . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38 STEREOLOGICAL ANALYSIS OF TERMINAL VILLI OF HUMAN PLACENTAS ASSOCIATED WITH EPH GESTOSIS Dinko Vitezić . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39 TRENDS IN THE UTILIZATION OF CARDIOVASCULAR DRUGS IN CROATIA DURING THE PERIOD 2007-2010 Viola Macolić-Šarinić, Pero Draganić, Josip Čulig, Marcel Leppée, Marinko Bilušić, Saša Žeželić . . . 40 COMPARATIVE ANALYSIS OF CARDIOVASCULAR DRUGS UTILISATION IN GENERAL HOSPITAL AND CLINICAL CENTER IN CROATIA AND BOSNIA AND HERZEGOVINA Mirza Dilić, Aleksandar Knežević, Sanja Sarić-Kužina, Anesa Eminović . . . . . . . . . . . . . . . . . . . . . . . . . . . 41 DIFFERENTIAL DIAGNOSIS OF CLEAR CELL TUMORS Nenad Vanis, Rusmir Mesihović, Aida Saray . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42 MODELLING THE EUROPEAN BURDEN OF DISEASE ASSOCIATED MALNUTRITION András Inotai, Mark Nuijten, Eric Roth, Refaat Hegazi, Zoltán Kaló . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43 FROM MORISKY TO HILL-BONE: MEASUREMENT OF ADHERENCE TO MEDICATION Josip Čulig, Marcel Leppee . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44 THE COST OF DIABETES MELLITUS IN MACEDONIA Donka Pankov, Zoran Sterjev, Ljubica Suturkova . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45 COST-EFFECTIVENESS OF INTERVENTIONS TO CONTROL DIABETES MELLITUS AND PREVENT COMPLICATIONS Terezija Šarić, Tamara Poljičanin, Željko Metelko . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46 SYMPTOMATIC THERAPY FOR COLD AND FLU – MACEDONIAN CASE 2011 Stevce Acevski, Vladimir Indov, Zoran Sterjev, Rubin Zareski . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47 ECONOMIC EVALUATION OF DECREASING PERSISTANT HYPERTENSION WITH RENAL DENERVATION DEVICE CUTTING COSTS OF HYPERTENSION COMMORBIDITIES IN UPCOMING CROATIAN PRACTICE Vanesa Benković, Ranko Stevanović, Ana Ivičević, Marko Matulović, Bojan Jelaković . . . . . . . . . . . . . 48 CODIFFICATION AS A METHOD IN RESEARCH ON ANIMAL MODELS IN PHARMACOECONOMICAL EFFICIENCY Iris Broman . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 49 THE ROLE OF PHARMACOECONOMICS IN MEDICINES REIMBURSEMENT DECISION-MAKING IN BOSNIA AND HERZEGOVINA Tarik Čatić, Igor Martinović, Begler Begović . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 50 EVALUATION OF UTILIZATION OF OLD VERSUS NEWER ANTIEPILEPTIC DRUGS IN REPUBLIC OF MACEDONIA Bojana Danilovska, Zoran Sterjev, Ljubica Suturkova . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 51 3
Page 3: FOLIA MEDICA FACULTATIS MEDICINAE U
Page 7 and 8: PRVI BOSANSKO-HERCEGOVAČKI I DRUGI
Page 9 and 10: Dear Colleagues and friends On beha
Page 11 and 12: Dear colleagues, dear friends, We c
Page 13 and 14: procedures. These clinical trials a
Page 15 and 16: Ensuring equity and availability of
Page 17 and 18: Reimbursement of expensive hospital
Page 19 and 20: Transferability of NICE recommendat
Page 21 and 22: Health Technology Assessment in Ser
Page 23 and 24: THE BLOCKADE OF SCIATIC NERVE AND P
Page 25 and 26: Showing the use of drugs in the Cli
Page 27 and 28: Burden of community acquired pneumo
Page 29 and 30: Pharmacoeconomic analysis comparing
Page 31 and 32: Impact of the Pharma Economic Act o
Page 33 and 34: Implementation of biological therap
Page 35 and 36: Comparative analysis of patient acc
Page 37 and 38: The economic cost analysis of the i
Page 39 and 40: Case study in transplantation and i
Page 41 and 42: STEREOLOGICAL ANALYSIS OF TERMINAL
Page 43 and 44: Comparative analysis of cardiovascu
Page 45 and 46: Modelling the European Burden of Di
Page 47 and 48: The cost of diabetes mellitus in Ma
Page 49 and 50: Symptomatic therapy for cold and fl
Page 51 and 52: Codiffication as a method in resear
Page 53 and 54: Evaluation of utilization of old ve
Page 55 and 56:
Comparison of cost effectivenes of
Page 57 and 58:
Cost-effectiveness of combined trea
Page 59 and 60:
Influence of increased linezolid ut
Page 61 and 62:
Antidiabetic drug expenditure in Bo
Page 63 and 64:
The frequency of administration of
Page 65 and 66:
Malnutrition in Croatia - where are
Page 67:
Zlatni sponzor PFIZER Brončani spo
show all

prvi bosansko-hercegovački i drugi jadranski kongres ...

Create successful ePaper yourself

Delete template?

Save as template?